EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma

Imran Ghayoor, Rida Ather, Munira Shakir, Nazish Khan, Salman Azmi

Pakistan Journal of Ophthalmology · 31.03.2026 · 42 (2)

DOI: 10.36351/pjo.v42i2.2205 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Pakistan Journal of Ophthalmology, online erschienen am 31.03.2026. Verfasst von Imran Ghayoor und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the short-term effectiveness and associated predictors of intraocular pressure (IOP) reduction following micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with glaucoma. Study Design: Prospective observational study. Place and Duration of Study: Conducted at Liaquat National Hospital, Karachi, from July 12, 2024, to January 13, 2025.

Methods

Patients with uncontrolled glaucoma undergoing MP-TSCPC were enrolled. IOP was measured at baseline, 1 month, and 3 months post-procedure. Treatment effectiveness was defined as a ≥20% reduction in IOP without need for further surgical intervention. Friedman test and Wilcoxon signed-rank tests assessed changes over time. Categorical associations were examined using chi-square test, and predictors of effectiveness were analyzed via univariate and multivariable logistic regression.

Results

A total of 97 eyes were analyzed. Median baseline IOP was 20 mmHg (IQR: 17–31), which significantly reduced to 16 mmHg (IQR: 14–22) at 1 month and 14 mmHg (IQR: 11–17) at 3 months (p < 0.001). Treatment was effective in 76 eyes (78.4%). Male gender (p < 0.001), longer glaucoma duration (p = 0.03), and moderate severity (p = 0.038) were significantly associated with effectiveness. In multivariable regression, only male gender remained an independent predictor (aOR = 10.59, 95% CI: 2.11–53.21, p = 0.004).

Conclusion

MP-TSCPC significantly lowered IOP at 1 and 3 months. Approximately four-fifths of patients achieved effective outcomes, with male gender being a strong predictor of success. The procedure appears safe and beneficial for short-term glaucoma control.

Zitieren

APA

Ghayoor, I., Ather, R., Shakir, M., Khan, N., & Azmi, S. (2026). Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma. Pakistan Journal of Ophthalmology, 42(2). https://doi.org/10.36351/pjo.v42i2.2205

Vancouver

Ghayoor I, Ather R, Shakir M, Khan N, Azmi S. Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma. Pakistan Journal of Ophthalmology. 2026;42(2). doi:10.36351/pjo.v42i2.2205

BibTeX
@article{Ghayoor2026,
  author = {Ghayoor, Imran and Ather, Rida and Shakir, Munira and Khan, Nazish and Azmi, Salman},
  title = {Effectiveness of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) Using the Longer Duration Protocol in Lowering IOP in Patients with Glaucoma},
  journal = {Pakistan Journal of Ophthalmology},
  year = {2026},
  volume = {42},
  number = {2},
  doi = {10.36351/pjo.v42i2.2205}
}
Kostenlos starten →